Every quarter, ARM publishes fresh data that highlights sector trends in clinical trials, investment, and developer growth. We supplement our data releases with periodic commentary, the Sector Snapshot, that contextualizes what’s new, what’s important, and why it matters.
Q1 2025 Update: New Sector Data Is Coming
ARM is still crunching the numbers to provide our sector-leading data. We plan to release our data in July, providing a comprehensive look at the first half of 2025.
We have partnered with a new data provider to curate richer, more timely information, evolving our methodology to deliver even deeper insights. You will see the same report structure, so you can continue drawing insights.
Access a full breakdown of global clinical trials within the cell and gene therapy sector.
A quick glimpse at the total number of therapeutic developers globally.
An overview of investment figures, equity performance, and financial deals that shape the sector.
For general inquiries regarding our data, or if you are interested in purchasing the curated Cell and Gene Therapy Dataset that ARM produces with its data partner, Global Data, please contact Patrick Richard, ARM’s Data & Analytics Lead, at prichard@alliancerm.org
ARM commentary that spotlights notable trends and stories driving the sector.
ARM’s latest quarterly update on the cell and gene therapy sector is now available. Dive in for a recap of the notable sector clinical, regulatory, and investment trends from Q1 2025.
ARM’s latest quarterly update on the cell and gene therapy sector is now available. Dive in for a recap of the notable sector clinical, regulatory, and investment trends from Q1 2025.
ARM’s latest quarterly update on the cell and gene therapy sector is now available. Dive in for a recap of the notable sector clinical, regulatory, and investment trends from Q1 2025.
ARM’s latest quarterly update on the cell and gene therapy sector is now available. Dive in for a recap of the notable sector clinical, regulatory, and investment trends from Q1 2025.
ARM’s latest quarterly update on the cell and gene therapy sector is now available. Dive in for a recap of the notable sector clinical, regulatory, and investment trends from Q1 2025.
